Schedule 13D ownership disclosure

OYSTER POINT PHARMA INC

Security class unavailable · CUSIP: 69242L106

Event date: 2023-01-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-008356
Form type
SC 13D/A
Filer
Oyster Point Pharma, Inc.
CIK
CIK 1720725
Filed
Jan 13, 2023
Reporting period
Jan 03, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub